Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
François B, Jafri HS, Chastre J, Sánchez-García M, Eggimann P, Dequin PF, Huberlant V, Viña Soria L, Boulain T, Bretonnière C, Pugin J, Trenado J, Hernandez Padilla AC, Ali O, Shoemaker K, Ren P, Coenjaerts FE, Ruzin A, Barraud O, Timbermont L, Lammens C, Pierre V, Wu Y, Vignaud J, Colbert S, Bellamy T, Esser MT, Dubovsky F, Bonten MJ, Goossens H, Laterre PF; COMBACTE Consortium and the SAATELLITE Study Group. François B, et al. Among authors: eggimann p. Lancet Infect Dis. 2021 Sep;21(9):1313-1323. doi: 10.1016/S1473-3099(20)30995-6. Epub 2021 Apr 21. Lancet Infect Dis. 2021. PMID: 33894131 Clinical Trial.
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.
Kollef M, Pittet D, Sánchez García M, Chastre J, Fagon JY, Bonten M, Hyzy R, Fleming TR, Fuchs H, Bellm L, Mercat A, Mañez R, Martínez A, Eggimann P, Daguerre M, Luyt CE; Prevention of Pneumonia Study (POPS-1) Trial Group. Kollef M, et al. Among authors: eggimann p. Am J Respir Crit Care Med. 2006 Jan 1;173(1):91-7. doi: 10.1164/rccm.200504-656OC. Epub 2005 Sep 28. Am J Respir Crit Care Med. 2006. PMID: 16192451 Clinical Trial.
Management of catheter-related infection.
Pagani JL, Eggimann P. Pagani JL, et al. Among authors: eggimann p. Expert Rev Anti Infect Ther. 2008 Feb;6(1):31-7. doi: 10.1586/14787210.6.1.31. Expert Rev Anti Infect Ther. 2008. PMID: 18251662 Free article. Review.
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.
Lu Q, Rouby JJ, Laterre PF, Eggimann P, Dugard A, Giamarellos-Bourboulis EJ, Mercier E, Garbino J, Luyt CE, Chastre J, Georgescu-Kyburz V, Rudolf MP, Gafner V, Lazar H, Koch H, Perez A, Krämer SD, Tamm M. Lu Q, et al. Among authors: eggimann p. J Antimicrob Chemother. 2011 May;66(5):1110-6. doi: 10.1093/jac/dkr046. Epub 2011 Mar 10. J Antimicrob Chemother. 2011. PMID: 21398296 Clinical Trial.
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
Que YA, Lazar H, Wolff M, François B, Laterre PF, Mercier E, Garbino J, Pagani JL, Revelly JP, Mus E, Perez A, Tamm M, Rouby JJ, Lu Q, Chastre J, Eggimann P. Que YA, et al. Among authors: eggimann p. Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1861-7. doi: 10.1007/s10096-014-2156-1. Epub 2014 May 24. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24859907 Clinical Trial.
Effective treatment of invasive Aspergillus fumigatus infection using combinations of topical and systemic antifungals in a severely burned patient.
Fournier A, Pantet O, Guerid S, Eggimann P, Pagani JL, Revelly JP, Hauser PM, Marchetti O, Fontanella S, Letovanec I, Ravat F, Berger MM, Pannatier A, Voirol P, Que YA. Fournier A, et al. Among authors: eggimann p. J Burn Care Res. 2015 Mar-Apr;36(2):e85-9. doi: 10.1097/BCR.0000000000000143. J Burn Care Res. 2015. PMID: 25127025
168 results